CPT® Code 88267

1. Indications

Chromosome analysis is indicated in several clinical scenarios where there is a concern for potential chromosomal abnormalities. The following conditions may warrant this procedure:

• Advanced Maternal Age - Women of advanced maternal age are at a higher risk for chromosomal abnormalities in their offspring, making chromosome analysis a critical assessment tool.
• Abnormal Prenatal Ultrasound Findings - Any unusual findings during routine prenatal ultrasounds may prompt further investigation through chromosome analysis to rule out genetic disorders.
• Abnormal Maternal Blood Screen Results - Positive results from maternal blood screenings that suggest potential chromosomal issues can lead to the recommendation for chromosome analysis.
• Previous Child with a Chromosome Abnormality - A history of a prior child with chromosomal abnormalities increases the likelihood of recurrence, thus necessitating chromosome analysis for subsequent pregnancies.
• Known Familial Chromosome Rearrangement - If there is a known familial history of chromosomal rearrangements, chromosome analysis can help assess the risk for the current pregnancy.
• Known Familial Genetic Disorder - Families with a history of genetic disorders may require chromosome analysis to evaluate the risk of passing these conditions to the offspring.

2. Procedure

The procedure for chromosome analysis involves several critical steps to ensure accurate results. The following outlines the detailed procedural steps:

• Step 1: Sample Collection - The first step involves the collection of amniotic fluid or chorionic villus samples. Amniotic fluid is typically collected through a procedure known as amniocentesis, where a thin needle is inserted into the uterus to extract fluid. Alternatively, chorionic villus sampling (CVS) may be performed, where a small sample of placental tissue is obtained. In both cases, special syringes are used to collect the samples, which are then placed in sterile screw-top tubes to prevent contamination.
• Step 2: Sample Preparation - Once the samples are collected, they are transported to the laboratory for analysis. In the case of CVS, any blood clots present in the specimen are carefully removed using a stereomicroscope and sterile gloves before placing the specimen in the screw-top tubes. This step is crucial to ensure that the sample is suitable for analysis.
• Step 3: Cell Identification and Analysis - In the laboratory, 15 cells are identified from the sample for direct analysis. This involves culturing the cells to promote growth and then preparing them for karyotyping. Karyotyping is the process of evaluating the size, shape, and number of chromosomes present in the cell samples.
• Step 4: Chromosome Banding - The banding technique is employed to enhance the visibility of the chromosomes. Giemsa banding, a common method, involves several steps including acetic acid fixation, air drying, and denaturing the chromosomes using proteolytic enzymes or other techniques, followed by Giemsa staining. Alternatively, fluorochrome and Q-banding stains may be used. This banding allows for the identification of individual chromosomes and any abnormalities in their structure.
• Step 5: Karyotype Evaluation - After banding, the chromosomes are examined under a microscope to identify any extra, missing, or abnormal positions of chromosome pieces. The results are then compiled into a karyotype report, which provides a visual representation of the chromosomal arrangement.

3. Post-Procedure

After the chromosome analysis is completed, the results are typically reviewed and interpreted by a geneticist or a qualified healthcare professional. The expected recovery from the procedures of amniocentesis or CVS is generally straightforward, with patients advised to rest and monitor for any unusual symptoms. Follow-up appointments may be scheduled to discuss the results of the chromosome analysis and any further steps that may be necessary based on the findings. It is important for patients to receive genetic counseling if abnormalities are detected, as this can provide support and information regarding potential implications for the pregnancy and future family planning.